A Phase ½ Exploring the Safety, Tolerability, and Efficacy of Pembrolizumab (MK-3475) in Combination with Epacadostat (INCB 24360) in Subjects with Selected Cancers - Regional Cancer Care Associates LLC

Clinical Trials

A Phase ½ Exploring the Safety, Tolerability, and Efficacy of Pembrolizumab (MK-3475) in Combination with Epacadostat (INCB 24360) in Subjects with Selected Cancers

Type of Cancer
Solid Tumor
Locations
Bethesda
Sponsor
Incyte
Protocol Number
INCB 24360-202
Cancer Diagnosis
To Learn More Call
201-510-0910